Implications of Chronic Intake of Finasteride for Androgenetic Alopecia in Prostate Carcinoma

    Sara Silva, Sílvia Afonso
    TLDR Chronic use of 1 mg/day finasteride for hair loss may delay prostate cancer diagnosis by lowering PSA levels.
    This document discusses the implications of chronic finasteride use, particularly at a dose of 1 mg/day for androgenetic alopecia, on prostate cancer diagnosis and prevention. Finasteride, a 5-alpha-reductase type 2 inhibitor, reduces dihydrotestosterone levels, which affects both hair follicles and prostate receptors. While finasteride at 5 mg/day is known to lower prostate-specific antigen (PSA) levels by up to 50% and may have a chemopreventive effect on prostate cancer, this study aims to determine if similar effects occur with the 1 mg/day dose used for hair loss. The concern is whether this lower dose also reduces PSA levels, potentially delaying prostate cancer diagnosis, and if it offers any chemopreventive benefits.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    3 / 3 results